Your browser doesn't support javascript.
loading
Bioactive adrenomedullin in sepsis patients in the emergency department is associated with mortality, organ failure and admission to intensive care.
Lundberg, Oscar H M; Rosenqvist, Mari; Bronton, Kevin; Schulte, Janin; Friberg, Hans; Melander, Olle.
Affiliation
  • Lundberg OHM; Department of Clinical Sciences, Anaesthesiology and Intensive Care, Medical Faculty, Lund University, Lund, Sweden.
  • Rosenqvist M; Department of Intensive and Perioperative Care, Skåne University Hospital, Malmö, Sweden.
  • Bronton K; Department of Clinical Sciences, Medical Faculty, Lund University, Malmö, Sweden.
  • Schulte J; Department of Infectious Diseases, Skåne University Hospital, Malmö, Sweden.
  • Friberg H; Department of Clinical Sciences, Medical Faculty, Lund University, Malmö, Sweden.
  • Melander O; Department of Internal Medicine, Skåne University Hospital, Malmö, Sweden.
PLoS One ; 17(4): e0267497, 2022.
Article in En | MEDLINE | ID: mdl-35482727
ABSTRACT

BACKGROUND:

Adrenomedullin is a vasoactive hormone with potentially prognostic and therapeutic value, which mainly has been investigated in intensive care unit (ICU) settings. The triaging in the emergency department (ED) of patients to the right level of care is crucial for patient outcome.

OBJECTIVES:

The primary aim of this study was to investigate the association of bioactive adrenomedullin (bio-ADM) with mortality among sepsis patients in the ED. Secondary aims were to investigate the association of bio-ADM with multiple organ failure (MOF), ICU admission and ED discharge.

METHODS:

In this prospective observational cohort study, adult sepsis patients in the ED (2013-2015) had blood samples collected for later batch analysis of bio-ADM. Odds ratios (OR) with 95% confidence interval (CI) for bio-ADM were calculated.

RESULTS:

Bio-ADM in 594 sepsis patients was analyzed of whom 51 died within 28 days (8.6%), 34 developed severe MOF, 27 were ICU admitted and 67 were discharged from the ED. The median (interquartile range) bio-ADM was 36 (26-56) and 63 (42-132) pg/mL among survivors and non-survivors, respectively, 81 (56-156) pg/mL for patients with severe MOF and 77 (42-133) pg/mL for ICU admitted patients. Each log-2 increment of bio-ADM conferred an OR of 2.30 (95% CI 1.74-3.04) for mortality, the adjusted OR was 2.39 (95% CI 1.69-3.39). The area under the receiver operating characteristic curve of a prognostic mortality model based on demographics and biomarkers increased from 0.80 to 0.86 (p = 0.02) when bio-ADM was added. Increasing bio-ADM was associated with severe MOF, ICU admission and ED discharge with adjusted ORs of 3.30 (95% CI 2.13-5.11), 1.75 (95% CI 1.11-2.77) and 0.46 (95% CI 0.32-0.68), respectively.

CONCLUSION:

Bio-ADM in sepsis patients in the ED is associated with mortality, severe MOF, ICU admission and ED discharge, and may be of clinical importance for triage of sepsis patients in the ED.
Subject(s)

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Sepsis / Adrenomedullin Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Humans Language: En Journal: PLoS One Journal subject: CIENCIA / MEDICINA Year: 2022 Document type: Article Affiliation country: Sweden

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Sepsis / Adrenomedullin Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Humans Language: En Journal: PLoS One Journal subject: CIENCIA / MEDICINA Year: 2022 Document type: Article Affiliation country: Sweden